Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
PMS-Fluconazole 50 mg tablets
Packaging. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns…
ONESOURCE SPECIALTY PHARMA LIMITED
Failed Impurities/Degradation Specifications
Inventia Healthcare Limited
Failed Dissolution Specifications
Haleon US Holdings LLC
Chemical Contamination: contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process.
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Breckenridge Pharmaceutical, Inc.
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Annora Pharma Private Limited
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Amgen, Inc.
Presence of Foreign Substance.
Amgen, Inc.
Presence of Foreign Substance.
Amgen, Inc.
CGMP Deviations
Elevate Oral Care
sub potency
Amgen, Inc.
CGMP Deviations
Amgen, Inc.
CGMP Deviations
Lupin Pharmaceuticals Inc.
Presence of Foreign Substance
Amneal Pharmaceuticals, LLC
Cross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
ChloraPrep 1 mL and 1.5 mL Applicator - Clear
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited
CGMP Deviations; deficiencies observed during FDA inspection